Table 3 Summary of HIV care and treatment programmatic factors, by clusters
| PROGRAMMATIC FACTORS |
CLUSTER 1 Traditional Model (n = 5 clinics) |
CLUSTER 2 Mixed Model (n = 10 clinics) |
CLUSTER 3 Task-Shifted Model (n = 4 clinics) |
|---|---|---|---|
| Clinic days Per Week (average clinic day is 7 h) | |||
| Average number of clinic days at the main ART site (min, max) | 4.6 (3,6) | 4.4 (2,6) | 4.8 (4,5) |
| Average number of clinic days at outreach sites (min, max) | 3.0 (0,5) | 1.3 (0,5) | 0.5 (0,2) |
| Total average number of clinic days (min, max) | 7.6 (3,11) | 5.7 (4,10) | 5.3 (5,6) |
| Time to ART initiation | |||
| > 7 days to determine eligibility | 0/5 (0%) | 6/10 (60%) | 2/4 (50%) |
| > 7 days to initiate AT if found eligible | 1/5 (20%) | 4/10 (40%) | 2/4 (50%) |
| Site requires at least 3 counselling sessions before ART initiation | 2/5 (40%) | 9/10 (90%) | 3/4 (75%) |
| One or more stock out of ART in the past 6 months | 1/5 (20%) | 0/10 (0%) | 4/4 (100%) |
| Time to Less Frequent ARV Drug Refill (every 2 months instead of monthly) | |||
| In the first month on ART | 0/5 (0%) | 0/10 (0%) | 0/4 (0%) |
| Between two and six months on ART | 0/5 (0%) | 2/10 (20%) | 0/4 (0%) |
| After six months on ART | 1/5 (20%) | 8/10 (80%) | 1/4 (25%) |
| Frequency of laboratory testing after 6 months on ART | |||
| CD4 cell count | |||
| Every 3 months | 1/5 (20%) | 2/10 (20%) | 0/4 (0%) |
| Every 6 months | 4/5 (80%) | 8/10 (80%) | 4/4 (100%) |
| Viral load testing | |||
| Never | 2/5 (40%) | 6/10 (60%) | 3/4 (75%) |
| As needed | 3/5 (60%) | 4/10 (40%) | 1/4 (25%) |
| Adherence support through the HIV care and treatment clinic | |||
| Require treatment supporter after ART initiation | 5/5 (100%) | 8/10 (80%) | 3/4 (75%) |
| Pill count during 1st six months on ART | 0/5 (0%) | 5/10 (50%) | 3/4 (75%) |
| Pill count after 1st six months on ART | 0/5 (0%) | 5/10 (50%) | 2/4 (50%) |
| Pill count after patient misses ARV drug refill appointment | 4/5 (80%) | 7/10 (70%) | 3/4 (75%) |
| People Living with HIV support group | 5/5 (100%) | 8/10 (80%) | 4/4 (100%) |
| Adherence support worker | 4/5 (80%) | 8/10 (80%) | 3/4 (75%) |
| Home-based care worker | 3/5 (60%) | 5/10 (50%) | 2/4 (50%) |
| Community-based services linked to the HIV care and treatment clinic | |||
| ARV drug distribution by providers or lay volunteers | 0/5 (0%) | 3/10 (30%) | 1/4 (25%) |
| Adherence support | 5/5 (100%) | 8/10 (80%) | 4/4 (100%) |
| Emotional or social support | 4/5 (80%) | 8/10 (80%) | 3/4 (75%) |
| Follow-up of missed appointments | 4/5 (80%) | 7/10 (70%) | 3/4 (75%) |
| Nutritional supplementation | 3/5 (60%) | 5/10 (50%) | 3/4 (75%) |
| Home based care | 4/5 (80%) | 7/10 (70%) | 4/4 (100%) |
| Referral for medical care | 4/5 (80%) | 7/10 (70%) | 4/4 (100%) |
| Follow-up of missed clinic or pharmacy appointment | |||
| Telephone contact | 4/5 (80%) | 9/10 (90%) | 4/4 (100%) |
| House visit by adherence support worker | 3/5 (60%) | 8/10 (80%) | 3/4 (75%) |
| House visit by healthcare worker | 1/5 (20%) | 5/10 (50%) | 1/4 (25%) |
| House visit by home-based care worker | 3/5 (60%) | 7/10 (70%) | 3/4 (75%) |
| Tracing of patients loss to follow-up | |||
| Telephone contact | 4/5 (80%) | 9/10 (90%) | 4/4 (100%) |
| House visit by adherence support worker | 4/5 (80%) | 8/10 (80%) | 2/4 (50%) |
| House visit by healthcare worker | 3/5 (60%) | 5/10 (50%) | 1/4 (25%) |
| House visit by home-based care worker | 3/5 (60%) | 7/10 (70%) | 1/4 (25%) |